Thus, in addition to the expression profiles of the EMC and ALL pathways, substrate specificity and catalytic properties of ccr-homologues, Ccr1 and AllR, may also play an important role when considering “cross-activity” of both enzymes in primary/secondary metabolic pathways. The gene discussed is CCR1; the disease is acute lymphoblastic leukemia.